InteRNA Gets Nod for US Patent, Plans IND for miRNA Melanoma Drug in Late 2013

—

by

Cheryl Stratos
in

Doug Macron is the editor of GenomeWeb’s Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail him here or follow his GenomeWeb Twitter account at @Genesilencing.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *